Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms

27 Nov 2021

Abstract excerpt

BACKGROUND: COVID-19 has caused millions of deaths globally, yet the cellular mechanisms underlying the various effects of the disease remain poorly understood. Recently, a new analytical platform for comprehensive analysis of plasma protein profiles using proximity extension assays combined with next generation sequencing has been developed, which allows for multiple proteins to be analyzed simultaneously...

Topics

Join the communities discussing this publication.

Advanced Proteomics Techniques and Applications
COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34844191
DOI: 10.1016/j.ebiom.2021.103723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsPMID 34844191Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read ↗

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Precise blood proteome profiling in an undiagnosed population with COVID-19Semantic proximity Read ↗

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsSemantic proximity Read ↗

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity AssessmentSemantic proximity Read ↗

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read ↗

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read ↗

Proteomic blood profiling in mild, severe and critical COVID-19 patientsSemantic proximity Read ↗

Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.